← Case Library

Clause 4.1

⚖ 74 PMCPA cases 🔒 Members see all 74 cases

What this clause covers

Promotional material must not be issued until a marketing authorisation has been granted. Pre-licence promotion — including at scientific meetings, in press releases, or via digital channels — is a serious breach. Special rules apply to briefing medical and non-medical staff.

PMCPA Cases — Clause 4.1

74 cases
📅 8 Mar 2026 · Pfizer

Pfizer letter requesting addition of Ecalta and Celsentri to hospital e-prescribing system ruled promotional without prescribing information

Clause 1.2 Clause 4.1
📅 8 Mar 2026

Astellas UK & Astellas Europe: incomplete prescribing information used for years (AUTH/2939/2/17, AUTH/2940/2/17)

Clause 2 Clause 4.1 Clause 9.1
📅 8 Mar 2026 · Dr Falk Pharma

Dr Falk Pharma: website product pages and external links lacked compliant prescribing information (AUTH/3154/2/19)

Clause 4.1 Clause 9.1
🔒

See all 74 cases for Clause 4.1

Case Library members get full access to every PMCPA ruling, searchable by clause, company, outcome, and sanction.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

Already a member? Sign in

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free